Clinical Experience of the Use of CT-P13, a Biosimilar to Infliximab in Patients with Inflammatory Bowel Disease: A Case Series
Crossref DOI link: https://doi.org/10.1007/s10620-014-3392-z
Published Online: 2014-10-18
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kang, Yun-Seong
Moon, Hyoung Ho
Lee, Seung Eun
Lim, Yun Jeong
Kang, Hyoun Woo
Text and Data Mining valid from 2014-10-18